ITEM 1(a). | NAME OF ISSUER: |
Trinity Biotech plc (the “Issuer”)
ITEM 1(b). | ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES: |
IDA Business Park, Bray, Co. Wicklow, Ireland
ITEM 2(a). | NAME OF PERSON FILING: |
This amended filing of Schedule 13G is being filed on behalf of the following persons (the “Reporting Persons”):
(i) Stonehill Capital Management LLC (“Management”)
(ii) Stonehill Institutional Partners, L.P. (“Fund”)
(iii) John Motulsky (“Motulsky”)
(iv) Jonathan Sacks (“Sacks”)
(v) Peter Sisitsky (“Sisitsky”)
(vi) Michael Thoyer (“Thoyer”)
(vii) Michael Stern (“Stern”)
(viii) Samir Arora (“Arora”)
ITEM 2(b). | ADDRESS OF PRINCIPAL BUSINESS OFFICE: |
c/o Stonehill Capital Management LLC
320 Park Avenue, 26th Floor
New York, NY 10022
| | |
Management: | | Delaware limited liability company |
Fund: | | Delaware limited partnership |
Motulsky: | | US Citizen |
Sacks: | | US Citizen |
Sisitsky: | | US Citizen |
Thoyer: | | US Citizen |
Stern: | | US Citizen |
Arora: | | US Citizen |
ITEM 2(d). | TITLE OF CLASS OF SECURITIES: |
Class ‘A’ Ordinary Shares, par value US$0.0109 per share (held through American Depositary Shares (CUSIP 896438306)), each representing four Class ‘A’ Ordinary Shares).
896438306
ITEM 3. | IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B) OR (C) CHECK WHETHER THE PERSON FILING IS A: |
Not applicable.
The information in items 1 and 5 through 11 on the cover pages on this Schedule 13G is hereby incorporated by reference. The amounts of securities reported as beneficially owned on this Schedule 13G are the number of American Depositary Shares that may be deemed to be beneficially owned by the Reporting Persons. Each American Depositary Share represents four of the Issuer’s Class ‘A’ Ordinary Shares.